Back to search results

Penny COPILOT Chatbot for Perinatal Opioid Use Disorder

This study is testing a new version of a text messaging program called Penny COPILOT. This program is designed to help pregnant or new mothers who are dealing with opioid use disorder (OUD). Penny COPILOT will provide educational and supportive messages to help with recovery and reduce feelings of loneliness. We are looking for about 20 women who are currently pregnant or within 6 weeks postpartum, are receiving treatment for OUD at a Penn-affiliated hospital, and can read and write in English. The main goal is to see if using Penny COPILOT can help reduce feelings of loneliness, as measured by the UCLA Loneliness Scale, over three months.

Study design
This is an interventional study with a planned enrollment of 20 women. It is not specified if this is a randomized or single-arm study.
What's involved
Assessments will occur at the beginning of the study and again at a 3-month follow-up. The study involves interacting with the Penny COPILOT chatbot.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06969261

Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT

Recruiting
NAAll AgesInterventionalSupportive care
University of Pennsylvania
~20 participants
Updated 2026-07-28 on ClinicalTrials.gov
What's tested:Penny COPILOT

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
UCLA Loneliness Scale.
Measured over During Aim 3 activities, assessments will occur at Baseline and at 3-month Follow-up.

Conditions

Perinatal Opioid Use Disorder
Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

2 sites across 1 states
Pennsylvania2

Study leadership

  • Sara L Kornfield, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

Sara L Kornfield, PhD
[email protected]
1-800-789-7366
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Biological females who are currently pregnant or within 6 weeks postpartum.
Able to read, write, and speak English at a 6th grade level.
Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder.
Receiving prenatal care and OUD care at a Penn affiliated hospital.

Exclusion

Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI).

What this trial measures

  • UCLA Loneliness Scale.During Aim 3 activities, assessments will occur at Baseline and at 3-month Follow-up.

    The UCLA Loneliness Scale (Version 3) is the most commonly used measure of loneliness, with strong test-retest reliability, high internal consistency, and validity.97 While the word "lonely" is never used explicitly in the 20-item scale, subjects are asked to report the frequency of specific experiences (e.g., "How often do you feel in tune with others around you?") on a 4-point Likert scale (1 = "I never feel this way" to 4 = "I often feel this way.") For dichotomous analysis of loneliness, we will use the loneliness severity threshold adapted from Doryab98 which defines "lonely" as having a score greater than 40, while "not lonely" is defined as having a score less than or equal to 40.